Dow Up 1.13% Nasdaq Up 1.41%

Theravance Inc. (THRX)

-NasdaqGS
16.02 Down 0.19(1.17%) Oct 31, 3:59PM EDT
|After Hours : 16.02 Up 0.00 (0.01%) Oct 31, 4:43PM EDT
Prev Close:16.21
Open:N/A
Bid:15.38 x 5000
Ask:16.80 x 2800
1y Target Est:27.57
Beta:1.12
Next Earnings Date:N/A
Day's Range:15.58 - 16.61
52wk Range:15.56 - 32.89
Volume:1,053,295
Avg Vol (3m):804,520
Market Cap:1.84B
P/E (ttm):N/A
EPS (ttm):-2.09
Div & Yield:0.50 (3.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
THRXDown 1.17%1.84B
AZNUp 0.47%92.12B
CBSTDown 0.29%5.49B
PFEUp 0.37%189.91B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):822.04
Ex-Dividend Date:26-Aug-14

Analysts

Annual EPS Est (Dec-14) :-1.36
Quarterly EPS Est (Dec-14) :-0.08
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback